Takeda partners with new biotech Ambys in liver disease

Retrieved on: 2018-08-07 19:15:00

Tags for this article:

Click the tags to see associated articles and topics

Takeda partners with new biotech Ambys in liver disease. View article details on hiswai:

Excerpt

<div>The partnership announcement coincided with Ambys' official launch with a $60 million Series A financing funded by <b>Third Rock Ventures</b> and Takeda.</div>

Article found on:

View Original Article